Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
David W. Miles, Eva Ciruelos, A. Schneeweiss, Fabio Puglisi, Tamar Peretz‐Yablonski, Mario Campone and 24 more
- Rank
- 70 of 3,031
- Percentile
- top 2.4%
- Where
- Annals of Oncology, 2021
- Citations
- 95
From the 2021 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.